221 – 230 of 459
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy
(
- Contribution to journal › Article
-
Mark
NF-κB regulates androgen receptor expression and prostate cancer growth
(
- Contribution to journal › Article
-
Mark
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Circulating prostate tumor cells detected by Reverse transcription-PCR in men with localized or castration-refractory prostate cancer : Concordance with CellSearch assay and association with bone metastases and with survival
(
- Contribution to journal › Article
-
Mark
Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
Systematic review of Pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer
(
- Contribution to journal › Article
-
Mark
In reply
(
- Contribution to journal › Letter
-
Mark
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy
(
- Contribution to journal › Article
-
Mark
Prostate cancer : Estimating the benefits of PSA screening
(
- Contribution to journal › Article
-
Mark
Cutpoints in clinical chemistry : Time for fundamental reassessment
(
- Contribution to journal › Article